Therefore, the results in TCGA cohort demonstrated that GZMA, GZMB, and IFNG in the low-risk group were highly expressed, while TGFB1 was elevated in high-risk breast cancer patients (p < 0.001) (Figure 5E). This evidence concerns the gene IFNG and breast carcinoma.